Scientist I/Scientist II, Analytical Development, CMC – Nurix – San Francisco, CA
Nurix's drug discovery approach is to either harness or inhibit the natural function of E3 ligases within the ubiquitin proteasome...
News Ticker
- [ April 14, 2022 ] CDD Vault Integrates with SnapGene Server for Web-Based Sharing of Plasmid Information News
- [ May 16, 2022 ] CoNextions Inc. Announces First Patient Treated with CoNextions TR™ Tendon Repair System, a Revolutionary Tendon Repair Implant News
- [ May 16, 2022 ] Study Finds that AI Model Can Help Optimize Ovulation Trigger Injection Timing to Improve Outcomes for IVF Patients News
- [ May 16, 2022 ] Blade Therapeutics Presents Data from Phase 1 and Preclinical Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference News
- [ May 16, 2022 ] Genoa Ventures Promotes Vikram Chaudhery, Ph.D., to Partner News
- [ May 16, 2022 ] Scientists are finally learning how to design proteins from scratch. Drug development may never be the same News
Copyright © 2022 Biotech Networks, LLC
